MedTrace Logo

Open-label Crossover Metformin Gum Versus Tablet in Healthy Volunteers

NCT00648869 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2009-10-27

No results posted yet for this study

Summary

Single-dose, randomized, open-label, cross over study. The study will have an open-label, 3 period, 3 treatments, and randomized design.

Each volunteer will receive a Metformin gum 2x250mg, Metformin gum 1x250mg \& Metformin tablet 500mg

Conditions

  • Healthy

Interventions

DRUG

metformin tablet, metformin gum

500 mg, 250 mg

Sponsors & Collaborators

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • Itamar Raz, MD · Hadassah Hebrew University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2008-10-31
Completion
2008-11-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00648869 on ClinicalTrials.gov